CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AMLX–Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in PBH at ObesityWeek® 2026 Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $AMLX–Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in PBH at ObesityWeek® 2026 Annual Meeting